AstraZeneca Vaccine Developer: COVID Herd Immunity ‘Not a Possibility,’ Believes Virus Will Become Seasonal

Professor Andrew Pollard, Director of the Oxford Vaccine Group (OVG), and a professor of Paediatric Infection and Immunity receives the Oxford University/AstraZeneca CCP virus vaccine from nurse Sam Foster at the Churchill Hospital in Oxford, England on Jan. 4, 2021. Steve Parsons/Pool Photo/AP

The director of the Oxford Vaccine Group said that because of the Delta COVID-19 variant, herd immunity is “not a possibility.”

“I think we are in a situation here with this current variant where herd immunity is not a possibility because it still infects vaccinated individuals,” professor Andrew Pollard, the director, told the UK’s All-Party Parliamentary Group on Tuesday, according to ITV.